Trials / Terminated
TerminatedNCT01887002
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Ono Pharma USA Inc · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to evaluate whether ONO-2952 modulates visceral pain perception produced by rectal distention in female patients with IBS-D
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-2952 | ONO-2952 Active tablets, every day for 2 weeks |
| DRUG | Placebo comparator | ONO-2952 Matching Placebo every day for 2 weeks |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2015-01-01
- First posted
- 2013-06-26
- Last updated
- 2016-02-25
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01887002. Inclusion in this directory is not an endorsement.